updated Wed. September 11, 2024
-
The Lincolnian Online
January 3, 2018
Media coverage about VBI Vaccines (NASDAQ:VBIV) has been trending somewhat positive this week, according to Accern. The research group identifies negative ... Also, CEO Jeff Baxter acquired 10,000 shares of the firm's stock in a transaction on Tuesday, December 12th. The shares were bought at anÃÂ ...
TrueBlueTribune
January 1, 2018
VBI Vaccines Inc, formerly SciVac Therapeutics Inc, is a biotechnology company. The Company is engaged in developing various technologies that focus on vaccine protection. It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines.
TrueBlueTribune
December 25, 2017
VBI Vaccines Inc, formerly SciVac Therapeutics Inc, is a biotechnology company. The Company is engaged in developing various technologies that focus on vaccine protection. It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines.
StockNewsTimes
December 23, 2017
VBI Vaccines Inc (TSE:VBV) Director Jeffrey Royston Baxter purchased 4,609 shares of the business's stock in a transaction dated Tuesday, December 12th. ... It is developing eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccine technology, a vaccineÃÂ ...
Sek Voice.com
December 21, 2017
Lastly one site said the gumballs have medicinal purposes related to a flu vaccine. I will be asking Wolkar Drug, Baxter drug-Walgreens, and Monarch pharmacy and Soda Shop to look into this. One site said chewing gum could be made from them, I sawed one open and chewed a bit and ended up usingÃÂ ...
StockNewsTimes
December 15, 2017
VBI Vaccines logo VBI Vaccines, Inc. – (NASDAQ:VBIV) CEO Jeff Baxter purchased 15,000 shares of the business's stock in a transaction on Tuesday, November 28th. ... It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines.
Dispatch Tribunal
December 9, 2017
VBI Vaccines logo VBI Vaccines Inc (TSE:VBV) Director Jeffrey Royston Baxter bought 15,000 shares of the stock in a transaction dated Tuesday, November ... It is developing eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccine technology, a vaccineÃÂ ...
Post Analyst
December 31, 1999
Multiple company employees have indulged in significant insider trading. VBI Vaccines Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that CEO, President Baxter Jeff has acquired 10,000 shares of VBI Vaccines Inc. (VBIV) in trading session dated Dec. 12, 2017.
TrueBlueTribune
December 7, 2017
VBI Vaccines Inc, formerly SciVac Therapeutics Inc, is a biotechnology company. The Company is engaged in developing various technologies that focus on vaccine protection. It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines.
Medgadget (blog)
December 7, 2017
By technology, the Pediatric Vaccine market is segmented into dendritic cells vaccines, live attenuated vaccines, synthetic vaccines, toxoid vaccines, inactivated vaccines, conjugate vaccines, recombinant vector vaccines and subunit vaccines. By disease, the Pediatric Vaccine market is segmented into ...
The Ledger Gazette
December 5, 2017
In other VBI Vaccines news, CEO Jeff Baxter purchased 15,000 shares of the firm's stock in a transaction dated Tuesday, November 28th. The stock was acquired at an average cost of $4.75 per share, with a total value of $71,250.00. Following the acquisition, the chief executive officer now owns 135,255Â ...
Newsient (blog)
December 4, 2017
The research covers the current market size of the Global Meningococcal Vaccines market and its growth rates based on 5 year history data along with company profile of key players/manufacturers such as GlaxoSmithKline, JN-International Medical, Novartis International, Sanofi, Pfizer, Baxter International ...
Post Analyst
December 4, 2017
Multiple company employees have indulged in significant insider trading. VBI Vaccines Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that CEO, President Baxter Jeff has acquired 15,000 shares of VBI Vaccines Inc. (VBIV) in trading session dated Nov. 28, 2017.
The Ledger Gazette
December 3, 2017
VBI Vaccines logo VBI Vaccines Inc. (TSE:VBV) Director Jeffrey Royston Baxter purchased 15,000 shares of the firm's stock in a transaction on Tuesday, ... It is developing eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccine technology, a vaccine ...
MENAFN.COM
December 2, 2017
The global meningitis vaccine market is segmented into vaccines such as polysaccharide vaccines, conjugate vaccines and combination vaccines. ... players of the global meningitis vaccine market which includes company profiling of GlaxoSmithKline plc, Baxter International, Pfizer Inc., Sanofi Pasteur SA, ...
The Ledger Gazette
December 1, 2017
In related news, CEO Jeff Baxter acquired 10,000 shares of VBI Vaccines stock in a transaction dated Monday, August 21st. The shares were purchased ... It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines. It is involved in various ...
Baxter Bulletin
December 1, 2017
UAMS has two cancer vaccines that are now in clinical testing. One, developed by Dr. Thomas Keiber-Emmons, is presently being tested to treat breast cancer but will soon be expanded to other cancers as well. A second vaccine, developed by Dr. Mayumi Nakagawa, is designed for people already ...
The Ledger Gazette
November 10, 2017
Also, CEO Jeff Baxter bought 10,000 shares of VBI Vaccines stock in a transaction that occurred on Monday, August 21st. The shares were acquired at ... It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines. It is involved in various ...
Lexology
November 6, 2017
A recent decision of Mr. Justice Max Barrett in the case of Jennifer Walsh –v- The Health Service Executive, Baxter AG and Baxter Healthcare Limited [2017] ... This personal injuries action arose out of injuries allegedly suffered by the Plaintiff following the administration of a dose of the swine flu vaccine.
MilTech
November 5, 2017
... the widespread use of vaccines and growing advances in genetics, immunology and ... The global market overview for meningitis vaccine looks promising ... include Medimmune, Biomed Pvt. Ltd, Nuron Biotech and Baxter.
StockNewsTimes
November 5, 2017
Canaccord Genuity began coverage on shares of VBI Vaccines, Inc. ... In other news, CEO Jeff Baxter bought 10,000 shares of VBI Vaccines stock in a ... in developing various technologies that focus on vaccine protection.
Dispatch Tribunal
November 3, 2017
Canaccord Genuity initiated coverage on shares of VBI Vaccines, Inc. (NASDAQ:VBIV) ... In related news, CEO Jeff Baxter purchased 10,000 shares of the ... in developing various technologies that focus on vaccine protection.
Medgadget (blog)
November 3, 2017
... Baxter International, Sanofi Pasteur, Merck, Novartis, Pfizer, Hualan, ... This new research study on Meningitis Vaccine Market throws light on ...
The Ledger Gazette
October 28, 2017
The company's eVLP vaccine platform allows for the design of ... In other VBI Vaccines news, CEO Jeff Baxter acquired 10,000 shares of the ...
The Ledger Gazette
October 26, 2017
In other VBI Vaccines news, CEO Jeff Baxter acquired 10,000 shares of ... in developing various technologies that focus on vaccine protection.
Baxter Bulletin
October 23, 2017
These FDA approved vaccines are designed to offer extra protection ... FLUAD: Available in the U.S. since last year, the FLUAD vaccine ...
TrueBlueTribune
October 22, 2017
Media stories about VBI Vaccines (NASDAQ:VBIV) have been trending positive ... In other news, CEO Jeff Baxter acquired 10,000 shares of the stock in a ... in developing various technologies that focus on vaccine protection.
Coos Bay World
October 16, 2017
Flu Shot Clinic 1-4 p.m., Coos County Courthouse, room 121, 250 N Baxter, Coquille. Vaccine protects against 4 types of flu virus. Cash price ...
Healthline
October 13, 2017
As the vaccine debate heats up, there may be more cases like this. ... such as the belief that vaccines contain dangerous ingredients, according to the ... Attorney Teri Dobbins Baxter, writing in the University of Cincinnati Law ...
Healthcare Packaging
October 6, 2017
Baxter's voluntary recall serves as a reminder of the importance of ... “We need to stop freezing vaccines and baking biologic products.
The Lake Country Echo
October 2, 2017
The CDC also recommends getting an annual flu vaccine, stating the ... Health clinics offer 10-minute appointments at all locations: Baxter, ...
StockNewsTimes
September 27, 2017
Its lead eVLP asset is a prophylactic cytomegalovirus vaccine. ... In other VBI Vaccines news, CEO Jeff Baxter purchased 10,000 shares of the ...
StockNewsTimes
December 31, 1999
VBI Vaccines logo VBI Vaccines Inc. (TSE:VBV) Director Jeffrey Royston Baxter bought 15,000 shares of the firm's stock in a transaction that occurred on ... It is developing eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccine technology, a vaccine ...
FDA.gov
December 31, 1999
We have been closely working with one supplier, Baxter, to help them restore production operations in their Puerto Rico facilities. ... protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical ...
StockNewsTimes
December 31, 1999
VBI Vaccines Inc, formerly SciVac Therapeutics Inc, is a biotechnology company. The Company is engaged in developing various technologies that focus on vaccine protection. It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines.
Otaku Reports
December 31, 1999
The report also presents forecasts for Pediatric Vaccines Sales ... Novartis, Takeda Pharmaceutical, Bavarian Nordic, Baxter, LG Life Sciences, ...
The Ledger Gazette
December 31, 1999
Zacks Investment Research upgraded shares of VBI Vaccines, Inc. (NASDAQ:VBIV) ... The company's eVLP vaccine platform allows for the design of ... In related news, CEO Jeff Baxter purchased 10,000 shares of the firm's ...
Dispatch Tribunal
December 31, 1999
The company's eVLP vaccine platform allows for the design of ... news, CEO Jeff Baxter purchased 10,000 shares of VBI Vaccines stock in a ...
Dispatch Tribunal
December 31, 1999
Press coverage about VBI Vaccines (NASDAQ:VBIV) has been trending positive ... In other news, CEO Jeff Baxter acquired 10,000 shares of the stock in a ... It has developed an enveloped virus like particle (eVLP) vaccine ...
Coos Bay World
December 31, 1999
Flu Shot Clinic 1-4 p.m., Coos County Courthouse, room 121, 250 N Baxter, Coquille. Vaccine protects against 4 types of flu virus. Cash price ...
Medgadget (blog)
September 2, 2017
... revenue and market share for each manufacturer, covering Pfizer, Baxter International, Inc., Bharat Serums and Vaccines Limited, Biotest AG.
StockNewsTimes
September 1, 2017
In other VBI Vaccines news, CEO Jeff Baxter purchased 10,000 shares ... in developing various technologies that focus on vaccine protection.
Investing News Network (registration)
August 30, 2017
VBI Vaccines Obtains IND Approval for Sci-B-Vac ... for Sci-B-Vac hepatitis b vaccine as an investigational new drug (IND) for a phase 3 clinical program. ... Phase 3 pivotal program,” said Jeff Baxter, President and CEO of VBI.
StreetInsider.com
August 30, 2017
VBI Vaccines Inc. (NASDAQ: VBIV) today announced that the U.S. Food ... program evaluating Sci-B-Vacî, VBI's third-generation hepatitis B vaccine. ... Phase 3 pivotal program," said Jeff Baxter, President and CEO of VBI.
Insider Tradings
August 24, 2017
VBI Vaccines (TSE:VBV) Director Jeffrey Royston Baxter bought 10,000 stocks of VBI Vaccines shares in a trade that took place on Mon, AugÃÂ ...
BioPharma-Reporter.com
August 23, 2017
Shire has sold the former Baxalta vaccine facility in Austria to Merck ... The site once manufactured a number of Baxter International's vaccinesÃÂ ...
StockNewsTimes
August 22, 2017
VBI Vaccines, Inc. – (NASDAQ:VBIV) CEO Jeff Baxter acquired 10,000 ... in developing various technologies that focus on vaccine protection.
FiercePharma
August 7, 2017
... plant from Shire that Merck will use to make animal vaccines. ... Shire has found a buyer for a former Baxter vaccine plant in Europe as it ... the 340,000-square-foot facility, which it will use for animal vaccine production.
Newsday
August 5, 2017
A vaccine to prevent Lyme disease is being fast-tracked for approval by the U.S. Food ... Luft's vaccine was licensed to the Illinois-based BaxterÃÂ ...
Market Realist
December 31, 1999
In 2Q17, Pfizer's Vaccines business generated revenues of ~$1.3 billion ... To read more about Prevnar 13 and Pfizer's Vaccine franchise, ... include Johnson & Johnson (JNJ), GlaxoSmithKline, Baxter, Biogen, and Eli Lilly.
|
news and opinion
|
